65,437 trials
Depression · Dual Diagnosis · Drug Addiction
Primary: Hamilton Depression Rating Scale (HAMD) Scores — 16.76; 17.65; 1.67; 16.24 score on a scale
Lymphoma · Non-Hodgkin Lymphoma · NHL
Primary: Phase 2: Complete Response (CR) Rate
HIV Infections · Contraception · Drug-drug Interaction
Primary: Hormonal Contraceptive Concentrations — 589; 1293; 542; 1761 pg/mL — p=0.306
Chronic Kidney Diseases
Primary: The Patient Activation Measure (PAM) — 60.8; 61.5; 1.73; 3.44 score on a scale
Alzheimer Disease · Mild Cognitive Impairment
Primary: Change in Alzheimer's Disease Knowledge Scale (ADKS) Score — 0.26; 1.15 score on a scale
Post-Operative Delirium
Primary: Confusion Assessment Method for the ICU (CAM-ICU) — 4; 1 Participants
Allergic Conjunctivitis
Primary: Change From Baseline Ocular Itching Score on High Pollen Days — -0.65; 0.16; -0.69 units on a scale
Bipolar Disorder · Panic Disorder · Generalized Anxiety Disorder
Primary: Clinician Global Improvement Scale (CGI-21) — 7.8; 3.4 units on a scale
Peripheral ICC
Primary: VPS G4 System Digital Data vs GE MAC 5500 Ecg Machine Data — 20 subjects who digital data was captured
Influenza
Primary: Safety - Serious Adverse Event — 0; 0; 0 SAEs
Metastatic Pancreatic Ductal Adenocarcinoma
Primary: The Incidence of DLTs in the First 56 Days (8 Weeks) of Dosing to Determine Tolerable Phase 2/3 Dose of Canakinumab, Spartalizumab, Nab-paclitaxel and Gemcitabine in…
Brain Cancer
Primary: Number of Participants Who Received PET/CT and MRI Perfusion Studies — 53; 95 Participants
PTSD · Cardiac Arrest
Primary: Change in PTSD Symptoms Over Time — 37.00; 25.90; 16.20 score on a scale — p=<0.001
Heart Failure
Primary: Number of Patients Included in the Dataset — 134 Participants
Caries Pit and Fissure Limited to Enamel
Primary: Retention of the Sealant — 0; 0; 164; 164 Sealants